Thomas Gerard Zernick bought $4,981 of BAFN
CEO at BayFirst Financial Corp.. 326 shares at an average of $15.28, traded May 1, 2025, filed May 2, 2025.
Score components
- +25RoleCEO
- 0Trade size$5k at market
- 0Relative to holdingsHoldings up 1.8%
- +4Price context22% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +9.5%, 3m -12.7%, 6m -40.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001649739-25-000117, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 1, 2025 | POpen-market purchase Common Stock | +326 | $15.28 | $4,981 | 18,727 | May 2, 2025 |
Related signals
Other insiders at BayFirst Financial Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | BAFNsell BayFirst Financial Corp. | Derek Steven Berset director | $3 0 shares | -0% | |
| 22Weak | BAFNbuy BayFirst Financial Corp. | Scott Joseph McKim EVP, Chief Financial Officer | $1,968 120 shares | +4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.